The global HealthTech industry is undergoing an exciting revolution, fostering a new multidisciplinary industry that is based on the synergy between different technologies from the fields of biology and engineering. This approach, known as “bio-convergence” has been identified by the government of Israel as the country’s next growth engine.
The course provides first-mover advantage and access global and local case studies, funding information and a fundamental understanding of what bio-convergence really is and the disruptive opportunities it brings.
Testimonials
For me, 8400 BioConvergence course was a 5-day networking experience, allowing me to further enjoy cutting-edge science presented in a patient-centric method. BioConvergence resides at the intersection of exponential vectors. 8400 brings this notion to practice.
Moran Almog, MD
For further information please contact bioconvergence@8400thn.org
Target Audience
People from academia (PhD+, PIs), industry and health organizations who seek to gain first-mover advantage and access global and local case studies, funding information and fundamental understanding of what BioConvergence really is and the disruptive opportunities it brings.
.jpeg)
.jpeg)
.jpeg)
Next program
Previous program